Skip to Content

Daxor Corp DXR

Morningstar Rating
$9.20 0.00 (< 0.01%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DXR is trading at a 625% premium.
Price
$9.21
Fair Value
$95.69
Uncertainty
Extreme
1-Star Price
$47.36
5-Star Price
$3.53
Economic Moat
Fqhmfl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DXR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.20
Day Range
$9.209.34
52-Week Range
$7.1110.15
Bid/Ask
$8.67 / $12.80
Market Cap
$44.50 Mil
Volume/Avg
70 / 1,521

Key Statistics

Price/Earnings (Normalized)
65.72
Price/Sales
32.05
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
750

Valuation

Metric
DXR
Price/Earnings (Normalized)
65.72
Price/Book Value
1.30
Price/Sales
32.05
Price/Cash Flow
Price/Earnings
DXR

Financial Strength

Metric
DXR
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
DXR
Return on Assets (Normalized)
0.88%
Return on Equity (Normalized)
0.90%
Return on Invested Capital (Normalized)
Return on Assets
DXR
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
XkhspmbvVvttz$151.2 Bil
Becton Dickinson & Co
BDX
FxbtbhpFqdtrzs$67.6 Bil
Alcon Inc
ALC
VnvnshywHfzhtl$44.2 Bil
ResMed Inc
RMD
WcwzgsdnQlyjxz$30.3 Bil
Coloplast A/S ADR
CLPBY
PwkxywsqQsmw$28.4 Bil
West Pharmaceutical Services Inc
WST
PylfktxwQywy$23.9 Bil
Hologic Inc
HOLX
YsbvfvdfWckbm$18.4 Bil
Baxter International Inc
BAX
RrmzgpvfZfdhg$18.2 Bil
The Cooper Companies Inc
COO
WyygkqtwsSrnrkzw$18.1 Bil
Teleflex Inc
TFX
JbqdKmym$10.8 Bil

Sponsor Center